Aim: Adverse drug reaction (ADR) reporting and monitoring activities are of vital importance for patient safety. It is a predominant ubiquitous preventable clinical issue. This study was conducted to assess the ADR in various departments. Methods: Standard forms were filled up by healthcare workers patients from January 2020 December 2021 different The causality appraisal ADRs finished utilizin...

The Food and Drug Administration Adverse Event Reporting System (FAERS) is the primary source for postmarketing pharmacovigilance. Though potentially highly useful, the database reflects reporting biases, stimulated reporting, and suffers from lack of standardization and the use of multiple drug synonyms. These biases can suggest adverse drug reactions (ADRs) where none exist, and can obscure o...

Objectives: To assess adverse drug reactions (ADRs) reporting and identify factors to improve ADR among community pharmacists in the Greater Accra Region of Ghana.Design: A quantitative cross-sectional study.Setting: Community pharmacies Ghana.Participants: We randomly selected 210 from a list Accra, Ghana. All participants had been practicing past one year, with this study being conducted June...

Pharmacovigilance is the subject that deals with the detection, assessment, understanding, and prevention of adverse effects of drugs, or any other drug-related problems. Ecopharmacovigilance is the science & activity concerning detection, assessment, understanding and prevention of adverse effects or other problems related to the presence of pharmaceuticals in the environment, which affect hum...

Sir, A single high dose of oral amoxicillin has been the main antibiotic regimen recommended for the prophylaxis of endocarditis since 1982, and there has been good compliance with this recommendation in the UK. However, the fear that the number of deaths from anaphylaxis associated with amoxicillin prophylaxis could exceed the number of deaths from endocarditis that might be prevented from pro...

Background: Breast cancer is responsible for 13% of deaths among women globally. The present study aimed to assess adverse drug reactions (ADRs) in breast patients receiving treatment a tertiary care teaching hospital. Methods: This retrospective and descriptive was conducted the oncology department at sree mookambika institute medical sciences, Kulasekharam, covering six months from May 2022 N...

Under-reporting of ADR may be associated with poor knowledge, attitudes and practices to pharmacovigilance. This study evaluated knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting following interventions. This longitudinal study included 36 healthcare professionals participating in ART program in a tertiary hospital. Interventions included group tr...

INTRODUCTION Pharmacovigilance, the monitoring of drug safety after marketing approval, highly depends on the adequate reporting of adverse drug reactions (ADRs). To improve pharmacovigilance awareness and future ADR reporting among medical students, we developed and evaluated a student-run pharmacovigilance programme. METHODS In this project, teams of medical students (first- to fifth-year) ...

Introduction: The purpose of this study was to assess dental care professionals' drug prescription knowledge, practices, and reporting adverse reactions (ADRs). Methods: A cross-sectional exploratory conducted by using a face-to-face survey administered sample dentists from tertiary hospitals in Adana, Türkiye. questionnaire consisted six sections with closed-ended items including sociodemograp...

The Food and Drug Administration Adverse Event Reporting System (FAERS) is the primary source for postmarketing pharmacovigilance. Though potentially highly useful, the database reflects reporting biases, stimulated reporting, and suffers from lack of standardization and the use of multiple drug synonyms. These biases can suggest adverse drug reactions (ADRs) where none exist, and can obscure o...